Patent · US Active

Amlodipine formulations

US10894039B2 · kind B2 · utility

8Cited by
24References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2020
Grant dateJan 19, 2021
Priority date—
Expiry dateApr 20, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.